Home / Sources / Select Committees / Public Accounts Committee / Roll out of the COVID:19 vaccine progra…
Index live · Last sync 23 May 2026
Select Committee · Public Accounts Committee

Roll out of the COVID:19 vaccine programme

Status: Closed Opened: 26 Jan 2022 Closed: 8 Nov 2022 9 recommendations 23 conclusions 1 report

This inquiry follows on from our February 2021 report on the development and rollout of the first vaccines in the UK The Committee will question senior officials at DHSC, NHS England and the UK Health Security Agency on how well placed the government is to meet its full objectives for the COVID-19 vaccine programme , …

Clear

Reports

1 report
Title HC No. Published Items Response
Eleventh Report - The rollout of the COVID-19 vaccine progr… HC 258 13 Jul 2022 32 Responded

Recommendations & Conclusions

4 items
5 Recommendation Eleventh Report - The rollout of the CO… Rejected

After starting with a portfolio of seven candidates, the UK’s vaccine supply for 2022 and...

After starting with a portfolio of seven candidates, the UK’s vaccine supply for 2022 and 2023 now relies primarily on just two, yet many of the risks that the ‘portfolio’ approach was intended to mitigate remain. The UK’s portfolio strategy aimed to optimise the chances of success in securing access …

Government response. The government disagrees with the recommendation to review the future procurement strategy for COVID-19 vaccines, stating that the current strategy is kept under constant review with expert advice. They cite agreements with developers that give access to updated vaccines and …
HM Treasury
10 Recommendation Eleventh Report - The rollout of the CO… Rejected

The vaccine programme still has some issues to address.

The vaccine programme still has some issues to address. In England, 2.98 million adults were still unvaccinated at the end of May 2022. Analysis by UKHSA has confirmed that full and booster vaccination reduces the risk of someone falling seriously ill, needing to go to hospital, or dying because of …

Government response. The government disagrees with the recommendation to set a challenge to reduce the number of unvaccinated adults to 2.5 million and achieve 80% booster uptake, arguing it is moving away from target-based approaches.
HM Treasury
19 Recommendation Eleventh Report - The rollout of the CO… Rejected

Since then, out of the original portfolio of seven candidates, six have been approved for...

Since then, out of the original portfolio of seven candidates, six have been approved for use in the UK to date.44 But with six vaccines to choose from, it is noteworthy that only three—AstraZeneca, Pfizer and Moderna—have actually been deployed in the UK and also that the only new contracts …

Government response. The government disagrees with the recommendation to review the future procurement strategy for COVID-19 vaccines, stating that the current strategy is kept under constant review with expert advice. They cite agreements with developers that give access to updated vaccines and …
HM Treasury
21 Recommendation Eleventh Report - The rollout of the CO… Rejected

The Taskforce also told us that the COVID-19 vaccine market was still developing and that...

The Taskforce also told us that the COVID-19 vaccine market was still developing and that it considered many different factors when deciding which vaccines to procure, including the evolution of the virus and improved learning about different types of vaccines and how they work.48 The Taskforce was confident that the …

Government response. The government disagrees with the recommendation to review the future procurement strategy for COVID-19 vaccines, arguing that the current portfolio approach is constantly reviewed with clinical and commercial expertise.
HM Treasury

Oral evidence sessions

1 session
Date Witnesses
28 Mar 2022 Amanda Pritchard · NHS England, Dame Dr Emily Lawson · NHS England and NHS Improvement, Dr Jenny Harries OBE · UK Health Security Agency, Madelaine McTernan · Department for Business, Energy and Industrial Strategy, Shona Dunn · Home Office View ↗

Correspondence

2 letters
DateDirectionTitle
8 Nov 2022 — Correspondence from Amanda Pritchard, Chief Executive, NHS England, re House of…
12 May 2022 — Correspondence from Amanda Pritchard, Chief Executive, NHS, re Follow up to the…